戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cid (1) was synthesized for potential use in boron neutron capture therapy.
2 eliver boronated EGF to EGFR (+) gliomas for boron neutron capture therapy.
3 o, and investigated as a potential agent for boron neutron capture therapy.
4 somal delivery and subsequent application in boron neutron capture therapy.
5  and BPA, and, subsequently, the efficacy of boron neutron capture therapy.
6 interesting templates as carriers of 10B for boron neutron capture therapy.
7 l-down, inhibition of hydrolytic enzymes and boron neutron capture therapy.
8 lored potential in traditional areas such as Boron Neutron Capture Therapy agents, but also as pharma
9                    Protons, neutrons, pions, boron-neutron capture therapy, and charged-nuclei therap
10 ligonucleotides are potential candidates for boron neutron capture therapy, antisense technology, and
11 e of sufficient amounts of 10B for effective boron neutron capture therapy ( approximately 10(8)-10(9
12                           The application of boron neutron capture therapy (BNCT) following liposomal
13                                   Success of boron neutron capture therapy (BNCT) is dependent on cel
14                                              Boron neutron capture therapy (BNCT) is dependent on the
15                           The application of boron neutron capture therapy (BNCT) mediated by liposom
16 ntan-1-yl] thymidine, designated N5-2OH, for boron neutron capture therapy (BNCT) of brain tumors usi
17                                              Boron neutron capture therapy (BNCT) using 4-[10B]borono
18                                              Boron neutron capture therapy (BNCT), a binary treatment
19                                              Boron neutron capture therapy (BNCT), an experimental tr
20 sized as potential boron delivery agents for boron neutron capture therapy (BNCT).
21 rborane 2 was also tested as a candidate for boron neutron capture therapy, but showed poor tumor ret
22 ses an exceptional challenge, because viable boron neutron-capture therapy by this method will requir
23 udy was to determine whether the efficacy of boron neutron capture therapy could be enhanced by means
24                             The viability of boron neutron capture therapy depends on the development
25                           These studies with boron neutron capture therapy for CIA suggest that this
26 nophenylalanine has been applied in clinical boron neutron capture therapy for the treatment of high-
27 the design and synthesis of therapeutics for boron neutron capture therapy of cancer.
28 d BSH, two clinically approved drugs used in boron neutron capture therapy of cancer.
29 te suggest that this agent may be useful for boron neutron capture therapy of cancer.
30 n-containing compounds that maybe useful for boron neutron capture therapy of tumors.
31 unoprotein-based targeting strategies to the boron neutron-capture therapy of cancer poses an excepti
32                           The application of boron neutron capture therapy to rheumatoid arthritis re
33 ic boron cluster system, previously used for boron neutron capture therapy, was modified by the addit
34 use of boronated EGF as a delivery agent for boron neutron capture therapy, which is based on the cap

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。